Should gastric aspirate be discarded or retained when gastric residual volume is removed from gastric tubes?
Access Status
Fulltext not available
Authors
Williams, Teresa
Leslie, Gavin
Date
2010Type
Journal Article
Metadata
Show full item recordCitation
Williams, Teresa A. and Leslie, Gavin D. 2010. Should gastric aspirate be discarded or retained when gastric residual volume is removed from gastric tubes? Australian Critical Care. 23 (4): pp. 215-217.
Source Title
Australian Critical Care
ISSN
School
School of Nursing and Midwifery
Remarks
The link to the journal’s home page is: http://www.elsevier.com/wps/find/journaldescription.cws_home/710660/description#description. Copyright © 2010 Elsevier B.V. All rights reserved
Collection
Abstract
Summary: Nursing care of patients with enteral feeding tubes is common in the intensive care unit but the evidence that surrounds the practice is limited. Recent research by Juve-Udina and colleagues (2010) "To return or to discard? Randomised trial on gastric residual volume management" compares two methods of managing gastric residual volume. This critique provides a brief summary of their research and critically appraises the paper. The implications for nursing practice are discussed.
Related items
Showing items related by title, author, creator and subject.
-
Flanagan, D.; Barker, N.; Nowell, C.; Clevers, H.; Ernst, M.; Phesse, T.; Vincan, Elizabeth (2017)The gastric epithelium consists of tubular glandular units, each containing several differentiated cell types, and populations of stem cells, which enable the stomach to secrete the acid, mucus and various digestive enzymes ...
-
Flanagan, D.; Vincan, Elizabeth; Phesse, T. (2017)© 2017 The British Pharmacological Society. Gastric cancer persists as a frequent and deadly disease that claims over 700000 lives annually. Gastric cancer is a multifactorial disease that is genetically, cytologically ...
-
Thiem, S.; Eissmann, M.; Elzer, J.; Jonas, A.; Putoczki, T.; Poh, A.; Nguyen, P.; Preaudet, A.; Flanagan, D.; Vincan, Elizabeth; Waring, P.; Buchert, M.; Jarnicki, A.; Ernst, M. (2016)About 5% to 10% of human gastric tumors harbor oncogenic mutations in the KRAS pathway, but their presence alone is often insufficient for inducing gastric tumorigenesis, suggesting a requirement for additional mutagenic ...